Clinical Trials – The Bloodline with LLS
Clinical Trials - The Bloodline with LLS
Podcast Description
A Podcast for Patients and Caregivers
Podcast Insights
Content Themes
The podcast focuses on a variety of critical cancer-related topics, including CAR T-cell therapy, challenges in treating acute myeloid leukemia (AML), and the evolving landscape of myeloma treatment. Episodes delve into specific conditions and treatments, featuring interviews that answer pressing questions from patients and caregivers, such as eligibility criteria and side effects of new therapies.
A podcast for patients and caregivers
What does a myelofibrosis (MF) diagnosis really mean, and how does it fit within a group of conditions called myeloproliferative neoplasms, or MPNs? In this episode, we’re joined by Dr. Tania Jain of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD, who helps break it all down in a clear and approachable way.
She discusses how myelofibrosis affects the bone marrow, common symptoms to watch for, and how treatment options are tailored to each person. From managing day-to-day challenges to understanding when more advanced treatments may be considered, this conversation focuses on what matters most to patients and families.
As Dr. Jain shares, “every patient writes their own story,” noting that advancing research offers genuine hope.
CLICK HERE to participate in our episode survey.
Mentioned on this episode:
- Myelofibrosis (MF)
- DIPSS/DIPSS plus myelofibrosis scoring
- Myelofibrosis: Charting the Course for Care
- Allogeneic stem cell transplantation
- Acute myeloid leukemia (AML)
- Clinical Trial Support Center
- Online Chat
Additional Blood Cancer United Support Resources:
- Information Specialists
- Financial support
- Free Nutrition Consultations
- Free telephone/web patient programs
- Free booklets
- Patient Community
- Support groups
- Caregiver support
- Caregiver Workbook
- Young Adult Resources
- Survivorship Workbook
- Advocacy and Public Policy
- Mental Health Resources
Episode supported by Takeda Oncology.
The post Myelofibrosis (MF): More Options, More Hope first appeared on The Bloodline with Blood Cancer United Podcast.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.